IBIO INC IBIO
ASignal's systematic analysis rates IBIO as Bearish.
Reflects the latest available analysis · analyzed Oct 30, 2026
The case on IBIO
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health score (0.9)
- Low debt-to-equity ratio (0.03x)
- High current and quick ratios (7.85x, 7.50x) indicating liquidity strength
- Gross margin at 100%
- Significant cash reserves ($88.04M) relative to market cap
- Negative operating margin (-30138%)
- Negative return on equity (-65.70%) and return on assets (-30.80%)
- Negative enterprise value (-$33.52M) and negative revenue growth (-100%)
- Extremely high price-to-sales ratio (404.18x)
- No recent news coverage or Reddit mentions indicating low market interest
See the full verdict on IBIO
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes IBIO
Most investors never get a second opinion, let alone several. ASignal runs IBIO past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.